Adalvo enters into strategic collaboration deal with Naari Pharma

07 December 2021

Adalvo is thrilled to announce that we have entered into a strategic collaboration deal with Naari Pharma, a vertically integrated women’s health pharmaceutical business, based in Bangalore, India.

In our strategic collaboration we have signed an agreement pertaining to 12 products, that will enable Adalvo to offer a wide-basket of oral contraceptive and hormonal replacement products, at a global level.

These assets will be readily available, with a very competitive manufacturing background, allowing Adalvo to enter into this market instantly. Moreover, having Naari as a key partner will further boost our potential of accessing difficult-to-make segments of the industry, such as hormones.

Adalvo’s General Manager, Mr. Anil Okay comments, “Here at Adalvo, we remain pro-active and resilient in our mission to offer high-value products to our partners. Engaging with Naari in this strategic collaboration, will boost and strengthen our portfolio, through the inclusion of this basket of ready-made hormonal products. This will enhance our presence in the women’s healthcare segment – something that we have been looking forward to achieving!”

Naari’s CEO Mr. Prithi S. Kochhar comments: "We are excited about our collaboration with Adalvo. We believe that Naari’s R&D and manufacturing capabilities in women’s health, combined with Adalvo’s extensive network and global presence will create value for our partners. This strategic collaboration will deliver an extensive women’s health portfolio with a secure supply in a short time".

Stay tuned, as we will continue to provide further news updates on this exciting collaboration.